Enhanced TDS
Knowde-enriched technical product data sheet
Identification & Functionality
- Food Ingredients Functions
- Pharma & Nutraceuticals Functions
Features & Benefits
- Benefit Claims (Health)
Applications & Uses
- Markets
- Dosage Form
Technical Details & Test Data
- Yo-yo Dieting Syndrome
- REGULID PLUS active principals affect specific stages of the adipocyte life cycle. 1,2-vinyldithiin in REGULID PLUS inhibits preadipocyte differentiation and reduces lipid accumulation in maturing preadipocytes.
- It also triggers lipolysis in mature adipocytes, and in combination with DADS, it reinforces even more the induction of lipolysis.
- Since a number of complexed interconnected cell signaling pathways are involved in regulating the adipocyte cycle, treating adipocytes with multiple natural molecules results in enhanced effects.
- By targeting preadipocyte differentiation, lipid filling in maturing preadipocytes and also by increasing lipolysis, REGULID PLUS offers a complete solution for adipocyte management during dieting and also during the stabilization period following a diet.
- By reducing the appearance of new adipocytes, reducing their capability for storing fat and increasing lipolysis, REGULID PLUS helps stabilize the amount of fat in the body, and reduce the unavoidable refilling of adipocytes after a diet.
- Metabolic Syndrome
- REGULID PLUS active principals have demonstrated their positive effects on regulation of Triglycerides and Good Cholesterol (HDL) levels in a published double-blind, randomized, placebo-controlled study demonstrated the efficacy of a garlic preparation with the same composition as REGULID PLUS on the different lipid blood fractions.
- REGULID PLUS is delivered with a complete package of information, including bioXtract proprietary.
- Pre-clinical efficacy trials evaluating the action of REGULID PLUS's active principal on in vitro adipocyte metabolism, Pre-clinical acute oral toxicity trial in rats showing no particular effect and classifying the product in the danger 5 category DL50 superior 5,000 mg/kg, Bibliographical Phase II double-blind, randomized, placebo-controlled clinical trial showing results obtained with a REGULID PLUS equivalent composition.